Tursi James Patrick 4
4 · Aralez Pharmaceuticals Inc. · Filed May 16, 2018
Insider Transaction Report
Form 4
Tursi James Patrick
Chief Medical Officer
Transactions
- Sale
Common Shares, without par value
2018-05-14$0.52/sh−9,348$4,882→ 242,052 total
Footnotes (2)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 27,730 restricted stock units, which were previously granted on May 11, 2017 and which vested on May 11, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $0.5206 to $0.5269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.